Biomaterials Market

Biomaterials Market Size, Share, and Growth Report by Product (Metallic, Natural, Ceramics, Polymers), by Application (Cardiovascular, Ophthalmology, Dental, Orthopedic, Wound Healing, Tissue Engineering, Plastic Surgery, Neurology), Geography Analysis and Competitive Landscape: Premium Insights Industry Size, Share, Growth, Research, and Forecast From 2022 to 2030

Biomaterials Market Overview

The Global Biomaterials Market size was valued at USD 134.70 billion in 2021 and is projected to reach USD 481.70 billion by 2030, growing at a CAGR of 15.21% during the forecast period.

The aging population, rising incidence of cardiovascular and orthopedic problems, technological advancements in medicine, and increasing public awareness of implanted devices all contribute to the market growth for biomaterials. In addition, increased government investment for R&D in biomaterials and growing consumer awareness of the benefits of biomaterials-based products all contribute to the market’s expansion. However, the high cost of biomaterial implants and compatibility problems are anticipated to impede market expansion. On the other hand, introducing new technologies, such as hydrogen scaffolding and decellularized dermal matrixes for grafting, along with new products in plastic surgery, wound healing, and neurology, are anticipated to present lucrative opportunities for the market’s expansion during the forecast period.

Biomaterials Market Segmentation:

The biomaterials market is segmented based on type and application. By type, the market is segmented into metallic, polymeric, ceramic, and natural. By application, the market is classified into cardiovascular, dental, orthopedic, wound healing, plastic surgery, ophthalmology, tissue engineering, neurological disorders, and drug delivery systems.

By application, the orthopedic application segment dominated the growth of the biomaterials market in 2021.

The orthopedic application segment dominated the growth of the biomaterials market in 2021. One of the elements promoting the segment’s expansion is the growing use of metallic biomaterials in orthopedic applications because of their strong load-bearing capacity. Additionally, it is anticipated that ongoing efforts by industry players to introduce new orthopedic implants will boost revenue growth. For instance, DiFusion Inc. got FDA approval for its Xiphos-ZF spinal interbody device in November 2019. This device is based on a different biomaterial called Zfuze, a mix of titanium and poly-ether-ketone. The cytokine indicators that produce inflammation and are linked to the development of fibrous tissue are significantly decreased due to this novel biomaterial.

By application, the plastic surgery application segment is anticipated to expand at a potential pace during the projected time frame.

The plastic surgery application segment is anticipated to expand at a potential pace during the projected time frame. The primary reason for the segmental growth of the market is the rise in aesthetic surgery and the use of biomaterials in these operations. According to the International Society of Aesthetic Plastic Surgery’s 2019 book, around 4.3 million cosmetic treatments were carried out in the United States in 2018, which boosted the segment’s growth. As per the 2019 International Society of Aesthetic Plastic Surgery publication, in the U.S., around 4.3 million cosmetic procedures were performed in 2018, which has positively influenced segment growth.

Biomaterials Market Dynamics:

Drivers:

Increased Government Engagement in the Development of Novel Biomaterials

Over the past few years, biomaterials have become more in demand and used in various medical applications. The development of innovative biomaterials is being supported by investments, funding, and grants from several government agencies and academic institutions. For instance, Drexel University awarded the National Science Foundation $200,000 in March 2018 to support research on the impact of macrophage behavior control by biomaterials on biomaterial vascularization. Such research and funding initiatives should encourage the creation of novel biomaterials, opening up a wide range of potential for the market’s expansion.

Expansion of the Healthcare Industry in Developing Nations

The biomaterials market in emerging nations is anticipated to expand significantly during the anticipated period. This is primarily due to the growing patient population, rising implanted device usage, more CVD awareness, rising disposable income, improved healthcare infrastructure, and less strict regulatory rules (in comparison to developed countries). In addition, the BRICS countries (Brazil, Russia, India, China, and South Africa) have some of the biggest economies in the world. By 2020, one-third of global healthcare spending, according to the World Economic Forum, will come from these emerging economies. Some of the critical factors anticipated to fuel demand for cutting-edge healthcare services and cutting-edge medical devices in the respective healthcare systems of these countries include the rising geriatric population, the growing demand for surgical procedures, and the rising incidence of target diseases. In the upcoming years, this is anticipated to present new growth prospects to participants in the biomaterials market.

Biomaterials Market Regional Analysis:

The Asia Pacific is expected to occupy the potential market growth during the forecast period

The Asia Pacific is expected to witness the most significant CAGR over the forecast period. The main driver of regional market expansion is the strategic actions taken by regional players to increase their presence in domestic and international markets. For instance, in November 2019, the U.S.-based AdvanSource Biomaterials and the Japan-based Mitsubishi Chemical struck a deal to buy each other’s thermoplastic polyurethane elastomer businesses. The company has announced that this acquisition will enable it to grow internationally and win a sizable portion of the worldwide market. The biomaterials industry in India is constantly expanding. Orthopedic, dental, and cardiovascular biomaterials dominate the Indian biomaterials market. The rise in orthopedic, cardiovascular, and dental operations is responsible for growing market shares for biomaterial, cardiovascular, and orthopedic items.

COVID-19 Impact Analysis

The latest novel coronavirus, COVID-19, is the infectious disease it causes. Various well-known pharmaceutical and biopharmaceutical firms, as well as small startups, have stepped forward to develop medications and vaccines that target the infection brought on by the novel coronavirus after the World Health Organization (WHO) formally declared the COVID-19 outbreak a pandemic. In the first quarter of 2020, the coronavirus outbreak affected business and economic operations worldwide. For instance, the COVID-19 situation has caused delays in aesthetic procedures, which primarily include cosmetic dentistry work and surgery like liposuction and breast implants.

Key Market Players and Competitive Landscape

The Major companies that contributed to the market expansion are BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and Gelita AG (Germany).

This report categorizes the biomaterials market as follows,

Biomaterials Market by Product Outlook (Revenue, USD Million, 2017 – 2030):

Metallic
Natural
Ceramics
Polymers

Biomaterials Market by Application Outlook (Revenue, USD Million, 2017 – 2030):

Cardiovascular
- Sensors
- Stents
- Guidewires
- Implantable Cardiac Defibrillators
- Pacemakers
- Vascular Grafts
- Others
Ophthalmology
- Synthetic Corneas
- Intraocular Lens
- Contact Lens
- Ocular Tissue Replacement
- Others
Dental
- Tissue Regeneration Materials
- Dental Implants
- Bone Grafts & Substitutes
- Dental Membranes
- Others
Orthopedic
- Joint Replacement Biomaterials
- Orthobiologics
- Bioresorbable Tissue Fixation Products
- Viscosupplementation
- Spine Biomaterials
- Others
Wound Healing
- Fracture Healing Device
- Adhesion Barrier
- Skin Substitutes
- Internal Tissue Sealant
- Surgical Hemostats
- Others
Tissue Engineering
Plastic Surgery
- Facial Wrinkle Treatment
- Soft Tissue Fillers
- Craniofacial Surgery
- Bioengineered Skins
- Peripheral Nerve Repair
- Acellular Dermal Matrices
- Others
Neurology
- Neural Stem Cell Encapsulation
- Shunting Systems
- Hydrogel Scaffold for CNS Repair
- Cortical Neural Prosthetics
- Others
Others

Biomaterials Market by Regional Outlook (Revenue, USD Million, 2017 – 2030)

1. North America
  - United States
  - Canada
2. Europe
  - Germany
  - United Kingdom
3. Asia Pacific
  - Japan
  - China
4. Latin America
  - Brazil
  - Mexico
5. Middle East and Africa (MEA)
  - South Africa

Biomaterials Market Report Scope
Report Attribute	Details
Market Size Value in 2022	USD 155.18 billion
Revenue Forecast in 2030	USD 481.70 billion
Growth Rate	CAGR of 15.21 % From 2023 to 2030
Base Year for Estimation	2021
Historical Data	2017 – 2022
Forecast Years	2023 – 2030
Quantitative Units	Revenue in USD million and CAGR from 2023 to 2030
Report Coverage	Revenue forecast, company ranking, Trends competitive landscape, and growth factors
Segments Covered	Product, Application, and Region
Regional Scope	North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope	U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico and Others
Key Companies Profiled	BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and Gelita AG (Germany)

Table of Content

Biomaterials Market Size, Share, Growth, and Forecast Report

1. Introduction
1.1. Report Description
1.1.1. Aim of the Report
1.1.2. Prospective Audience
1.1.3. Unique Selling Prepositions and Key Takeaways from the Report
1.2. Scope of the Research Study
1.3. Approach/Research Methodology
1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Expert Panel Review
1.3.4. Market Data Breakdown and Data Triangulation
1.3.5. Research Approach for Market Size Estimation
1.3.5.1. Top-Down Approach
1.3.5.2. Bottom-Up Approach
1.3.6. Key Assumptions
1.4. Market Segmentation
1.4.1. Product
1.4.2. Application

2. Biomaterials Market Overview
2.1. Introduction
2.2. Analysis by Product, 2017-2030 (US$ Billion)
2.3. Analysis by Application, 2017-2030 (US$ Billion)
2.4. Market Analysis by Region, 2017-2030 (US$ Billion)

3. Biomaterials Market Dynamics
3.1. Introduction
3.2. Growth Drivers
3.3. Growth Restraints
3.4. Growth Opportunities
3.5. Porter’s Five Forces Analysis
3.5.1. Threat of New Entrants
3.5.2. Bargaining Power of Buyers/Consumers
3.5.3. Bargaining Power of Suppliers
3.5.4. Threat of Substitute Products
3.5.5. Intensity of Competitive Rivalry
3.6. Attractiveness Analysis
3.6.1. Product
3.6.2. Application
3.6.3. Region
3.7. Value Chain Analysis

4. Biomaterials Market Competition Analysis
4.1. Biomaterials Market Share Analysis by Company, 2019 – 2021
4.1.1. Top 3 Players, 2019 – 2021
4.1.2. Top 6 Players, 2019 – 2021
4.2. Strategic Initiatives
4.2.1. New Products Launch
4.2.2. Mergers/Acquisitions
4.2.3. Agreement and Collaborations
4.2.4. Partnerships, Joint Ventures, Expansion, and Distribution

5. Global Biomaterials Market Analysis by Product and Application, 2017-2030 (US$ Billion)
5.1. Product
5.1.1. Global Biomaterials Market Share, by Product, 2021 and 2030
5.1.2. Global Biomaterials Market Revenue, by Product, 2017-2030 (US$ Billion)
5.1.3. By Metallic Market Analysis 2017-2030 (US$ Billion)
5.1.4. By Natural Market Analysis 2017-2030 (US$ Billion)
5.1.5. By Ceramics Market Analysis 2017-2030 (US$ Billion)
5.1.6. By Polymers Market Analysis 2017-2030 (US$ Billion)

5.2. Application
5.2.1. Market Share, by Application, 2021 and 2030
5.2.2. Market Revenue, by Application, 2017-2030 (US$ Billion)
5.2.3. By Cardiovascular Market Analysis 2017-2030 (US$ Billion)
5.2.4. By Ophthalmology Market Analysis 2017-2030 (US$ Billion)
5.2.5. By Dental Market Analysis 2017-2030 (US$ Billion)
5.2.6. By Orthopedic Market Analysis 2017-2030 (US$ Billion)
5.2.7. By Wound Healing Market Analysis 2017-2030 (US$ Billion)
5.2.8. By Tissue Engineering Market Analysis 2017-2030 (US$ Billion)
5.2.9. By Plastic Surgery Market Analysis 2017-2030 (US$ Billion)
5.2.10. By Neurology Market Analysis 2017-2030 (US$ Billion)
5.2.11. By Others Application Market Analysis 2017-2030 (US$ Billion)

6. Global Biomaterials Market Product Analysis by Region, 2017-2030 (US$ Billion)
6.1. Metallic Market Analysis 2017-2030 (US$ Billion)
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East & Africa
6.2. Natural Market Analysis 2017-2030 (US$ Billion)
6.3. Ceramics Market Analysis 2017-2030 (US$ Billion)
6.4. Polymers Market Analysis 2017-2030 (US$ Billion)

7. Global Biomaterials Market Application Analysis by Region, 2017-2030 (US$ Billion)
7.1. Cardiovascular Market Analysis 2017-2030 (US$ Billion)
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Latin America
7.1.5. Middle East & Africa
7.2. Ophthalmology Market Analysis 2017-2030 (US$ Billion)
7.3. Dental Market Analysis 2017-2030 (US$ Billion)
7.4. Orthopedic Market Analysis 2017-2030 (US$ Billion)
7.5. Wound Healing
7.6. Tissue Engineering
7.7. Plastic Surgery
7.8. Neurology
7.9. Others

8. Biomaterials Market Analysis by Geography, 2017-2030 (US$ Billion)
8.1. North America Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.1.1. U.S. Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.1.1.1. Product
8.1.1.2. Application
8.1.2. Canada Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.1.3. Mexico Biomaterials Market Analysis 2017-2030 (US$ Billion)

8.2. Europe Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.1. UK Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.1.1. Product
8.2.1.2. Application
8.2.2. France Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.3. Germany Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.4. Spain Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.5. Russia Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.6. Italy Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.7. Rest of Europe Biomaterials Market Analysis 2017-2030 (US$ Billion)

8.3. Asia Pacific Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.1. China Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.1.1. Product
8.3.1.2. Application
8.3.2. Japan Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.3. South Korea Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.4. India Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.5. Australia Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.6. Southeast Asia Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.7. Taiwan Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.8. Rest of Asia Pacific Biomaterials Market Analysis 2017-2030 (US$ Billion)

8.4. Latin America Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.4.1. Brazil Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.4.1.1. Product
8.4.1.2. Application
8.4.2. Argentina Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.4.3. Rest of Latin America Biomaterials Market Analysis 2017-2030 (US$ Billion)

8.5. Middle East Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.5.1. Israel Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.5.1.1. Product
8.5.1.2. Application
8.5.2. Turkey Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.5.3. Saudi Arabia Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.5.4. UAE Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.5.5. Rest of Middle East Biomaterials Market Analysis 2017-2030 (US$ Billion)

8.6. Africa Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.6.1. Egypt Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.6.1.1. Product
8.6.1.2. Application
8.6.2. South Africa Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.6.3. Rest of Africa Biomaterials Market Analysis 2017-2030 (US$ Billion)

9. Company Profiles
9.1. BASF SE (Germany)
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Covestro AG (Germany)
9.3. Celanese Corporation (US)
9.4. Corbion (Netherlands)
9.5. Royal DSM (Netherlands)
9.6. Evonik Industries (Germany)
9.7. Carpenter Technology Corporation (US)
9.8. Berkeley Advanced Biomaterials (US)
9.9. Cam Bioceramics B.V. (Netherlands)
9.10. CoorsTek Inc. (US)
9.11. CeramTec (Germany)
9.12. Gelita AG (Germany)

10. COVID-19 Impact Analysis
10.1. Global Biomaterials Market, 2020 – 2030, Pre-V/S Post COVID 19
10.2. Estimated Impact of The Coronavirus (Covid-19) Epidemic on the Biomaterials Market Size In 2022, By Scenario
10.3. Impact on Supply Chain and Production in Biomaterials Market
10.4. Impact on Import and Export

11. Import-Export Analysis
11.1. North America Biomaterials Import-Export, 2017 – 2021
11.2. Europe Biomaterials Import-Export, 2017 – 2021
11.3. Asia Pacific Biomaterials Import-Export, 2017 – 2021
11.4. Latin America Biomaterials Import-Export, 2017 – 2021
11.5. Middle East America Biomaterials Import-Export, 2017 – 2021
11.6. Africa Biomaterials Import-Export, 2017 – 2021

12. Biomaterials Marketing Channel Analysis
12.1. Marketing Channel
12.1.1. Direct Marketing
12.1.2. Indirect Marketing
12.1.3. Development Trend
12.2. Market Positioning

13. Biomaterials Manufacturing Cost Analysis
13.1. Key Raw Materials
13.2. Key Raw Material Suppliers
13.3. Market Concentration Rate
13.4. Manufacturing Cost Structure
13.5. Process Analysis

14. Conclusion

Biomaterials Market by Product Outlook (Revenue, USD Million, 2017 – 2030):

Metallic
Natural
Ceramics
Polymers

Biomaterials Market by Application Outlook (Revenue, USD Million, 2017 – 2030):

Cardiovascular
- Sensors
- Stents
- Guidewires
- Implantable Cardiac Defibrillators
- Pacemakers
- Vascular Grafts
- Others
Ophthalmology
- Synthetic Corneas
- Intraocular Lens
- Contact Lens
- Ocular Tissue Replacement
- Others
Dental
- Tissue Regeneration Materials
- Dental Implants
- Bone Grafts & Substitutes
- Dental Membranes
- Others
Orthopedic
- Joint Replacement Biomaterials
- Orthobiologics
- Bioresorbable Tissue Fixation Products
- Viscosupplementation
- Spine Biomaterials
- Others
Wound Healing
- Fracture Healing Device
- Adhesion Barrier
- Skin Substitutes
- Internal Tissue Sealant
- Surgical Hemostats
- Others
Tissue Engineering
Plastic Surgery
- Facial Wrinkle Treatment
- Soft Tissue Fillers
- Craniofacial Surgery
- Bioengineered Skins
- Peripheral Nerve Repair
- Acellular Dermal Matrices
- Others
Neurology
- Neural Stem Cell Encapsulation
- Shunting Systems
- Hydrogel Scaffold for CNS Repair
- Cortical Neural Prosthetics
- Others

Methodology

Qualitative Analysis:

Industry Status and Trends
Market segment by regions, types, applications, and forecast
Market opportunities, potential, government policies, and influence factors.

Quantitative Analysis:

Market size (value, historical data, and forecast (2017-2030)
Market size by types, regions, and applications, from 2017 to 2030.
Market forecast based on the potential demand from downstream clients/buyers, government, influence factors, and the total economic indication, maybe occur in the following years.

Research Data Source:

Secondary Data

Secondary sources incorporate yearly reports, press releases, and investor presentations of companies; Journal of Science, authorised statistical yearbook, National Customs, Industry Association; Secondary research has mostly been functional to obtain key information about the industry’s supply chain, the market downstream buyers, technical dynamics development trends, the main vendors of this market, and market classification & segmentation according to the industry trends, regional markets, and key developments from a market and business oriented viewpoint.

Key Data from Secondary
Items	Source
Market Size (Value & Volume)	Industry Association
	Magazines
	Journals
	Press Releases
	Statistical Yearbook
	National Customs
Revenue of Companies	Paid Databases
	Data Centre
	Annual Reports
	Hoover
	Public Databases
	Bloomberg Business
Qualitative Analysis	Company Annual Reports
	Press Releases
	Industry Associations

Primary Data

In the primary research procedure, various sources from both the Sales and consumption sides were interviewed to acquire qualitative and quantitative information for this report. The primary sources from the Sales side include key product manufacturers (and their competitors), industry experts, industry association, research institutions, distributors, dealers, and traders, as well as the raw materials suppliers and producers, etc. The primary sources from the consumption side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and associated key executives from various key companies and organizations functioning in the global market. Primary research was led to identify segmentation types, product price range, product applications, key players, raw materials supply and downstream consumption, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Data from Primary
Items	PARAMETER	KEY DATA
Market Segmented by Regions	Total Market Size and Regional Market Status Growth Rate Forecast from 2022-2030	Major Regions: North Americas, Europe, Asia Pacific, Middle East and Africa, South Americas, etc. Market Status and Forecast
Submarket by Types	Historical (2017-2021) and Forecast (2022-2030) Data	Value and Growth Rate of Different Downstream Applications
Submarket by Applications	Historical (2017-2021) and Forecast (2022-2030) Data	Company Annual Reports Press Releases Industry Associations

Market Size Estimation

The top-down and bottom-up methods have been employed to estimate and forecast the market size in each region, different types, and applications. The most important vendors in the market have been discovered through secondary research and their market shares in the individual regions were determined through primary and secondary research.

Key players in the market are identified through secondary research and their market incomes are determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers, whereas primary research included extensive interviews of key opinion leaders and industry specialists such as knowledgeable front-line staff, directors, CEOs, and marketing executives. The percentage splits, market shares, growth rate, and breakdowns of the product markets are determined by using secondary sources and confirmed through primary sources.

All percentage shares split, and breakdowns have been determined using secondary sources and validated through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, examined in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Frequently Asked Questions

The Global Biomaterials Market size was valued at USD 134.7 billion in 2021 and is projected to reach USD 481.7 billion by 2030.

The global biomaterials market is poised to grow at a CAGR of 15.21 % from 2023 to 2030.

BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and Gelita AG (Germany)

The Asia Pacific is expected to occupy the potential market growth during the forecast period.

Get in Touch with Us

+1 (310) 601-4227 (US)

sales@beyondmarketinsights.com